Skip to main content
Humedix Co., Ltd. logo

Humedix Co., Ltd. — Investor Relations & Filings

Ticker · 200670 ISIN · KR7200670008 KO Manufacturing
Open in API
Filings indexed 317 across all filing types
Latest filing 2026-02-20 Investor Presentation
Country KR South Korea
Listing KO 200670

About Humedix Co., Ltd.

https://humedix.com/eng/home.php?go=Ame…

Humedix Co., Ltd. is a healthcare company that develops and manufactures biological and pharmaceutical products focused on human health and beauty. The company specializes in hyaluronic acid-based applications, producing medical devices such as dermal fillers and arthritis treatments. Its portfolio also includes prescription medicines, active pharmaceutical ingredients (APIs), and functional cosmetics. Additionally, Humedix offers Contract Manufacturing Organization (CMO) services within the healthcare sector.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Investor Presentation Classification · 95% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) event (Non-Deal Roadshow and Conference call). It provides details such as date, location, target audience, and purpose. Since it is an announcement of an upcoming event rather than the presentation materials themselves, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2026-02-20 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 98% confidence The document is a regulatory announcement from Humedix regarding the determination of a record date for cash/in-kind dividends. It specifies the record date (2026-04-03) and the purpose (determining shareholders for the 23rd fiscal year dividend). Since it announces the dividend record date rather than the specific dividend amount or payment details, and fits the regulatory disclosure format for corporate actions, it is classified as a general regulatory filing.
2026-02-13 Korean
공정거래자율준수프로그램운영현황
Governance Information Classification · 95% confidence The document is a detailed report titled '2025 Operating Results and 2026 Operating Plan for the Fair Trade Compliance Program (CP)' for Humedix. It outlines specific governance activities, internal audits, training programs, and compliance management systems (ISO 37301). While it relates to governance, it is a specific report on the company's internal compliance program performance rather than a general governance policy document. Given the nature of the content—detailing internal rules, board oversight, and compliance management practices—it falls under the Governance Information category.
2026-02-13 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Humedix regarding the decision to pay a cash dividend. It specifies the dividend amount per share, the total dividend amount, the record date, and the payment date. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2026-02-13 Korean
매출액또는손익구조30%(대규모법인은15%)미만변동(자율공시)
Audit Report / Information Classification · 95% confidence The document is a regulatory filing from a Korean company (Humedix) disclosing financial results (revenue, operating profit, net income) for the fiscal year 2025 compared to 2024. It is labeled as a 'voluntary disclosure' regarding changes in revenue or profit structure that are below the mandatory reporting threshold (30% for large corporations, 15% for others). This type of filing is a standard periodic financial announcement in the Korean market, which falls under the 'Earnings Release' category as it provides key financial highlights before the final audited annual report is published. FY 2025
2026-02-13 Korean
수시공시의무관련사항(공정공시)
Notice of Dividend Amount Classification · 95% confidence The document is a 'Fair Disclosure' (공정공시) announcement from Humedix regarding their mid-to-long-term dividend policy. It outlines the dividend per share targets, frequency, and strategy for the years 2026-2028. Since it is a regulatory announcement regarding corporate policy and financial strategy that does not fit into specific categories like 'Notice of Dividend Amount' (which usually refers to a specific declared dividend) or 'Earnings Release', it is best classified as a general regulatory filing.
2026-02-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.